BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7447028)

  • 1. Spectrophotometric determination of phenobarbitone, methylphenobarbitone and phenytoin in tablets.
    Wahbi AM; Bararay M
    Analyst; 1980 Sep; 105(1254):855-60. PubMed ID: 7447028
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous determination of phenobarbital, phenytoin and methylphenobarbital in tablet formulations by HPLC.
    Vio L; Mamolo MG; Furlan G
    Farmaco Prat; 1988 May; 43(5):157-64. PubMed ID: 3181414
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous spectrophotometric determination of phenobarbital, phenytoin and methylphenobarbital in pharmaceutical preparations by using partial least-squares and principal component regression multivariate calibration.
    Boeris ; Luco JM; Olsina RA
    J Pharm Biomed Anal; 2000 Dec; 24(2):259-71. PubMed ID: 11130205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of two ternary mixtures containing phenobarbitone by second derivative of the ratio spectrum-zero-crossing and HPLC methods.
    El-Gindy A; Emara S; Hadad GM
    Farmaco; 2003 May; 58(5):377-90. PubMed ID: 12729832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of orthogonal functions to the spectrophotometric determination of phenytoin and phenobarbitone in pharmaceutical preparations.
    Amer MM; Ahmad AK; Hassan SM
    J Pharm Pharmacol; 1977 Jun; 29(6):355-7. PubMed ID: 18572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of magnesium silicate adsorption chromatography to the determination of mephobarbital and diphenylhydantoin in tablets.
    Diliberto JJ
    J Pharm Sci; 1969 Jun; 58(6):747-9. PubMed ID: 4308091
    [No Abstract]   [Full Text] [Related]  

  • 7. An improved UV-spectrophotometric method for routine barbiturate monitoring.
    Jeremić V; Nikolić R
    J Clin Chem Clin Biochem; 1976 Oct; 14(10):479-83. PubMed ID: 993734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrophotometric determination of papaverine, theophylline, and phenobarbitone in some pharmaceutical preparations.
    Moussa AF
    Pharmazie; 1978 May; 33(5):296. PubMed ID: 674342
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous spectrophotometric determination of diphenylhydantoin and phenobarbital in biologic specimens.
    Wallace JE
    Clin Chem; 1969 Apr; 15(4):323-30. PubMed ID: 5780773
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue assay of phenobarbital, phenytoin and p-hydroxyphenytoin by high-performance liquid chromatography.
    Stout SA; DeVane CL
    J Chromatogr; 1984 Mar; 285(3):500-8. PubMed ID: 6715454
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors influencing plasma phenobarbitone levels in epileptic patients.
    Eadie MJ; Lander CM; Hooper WD; Tyrer JH
    Br J Clin Pharmacol; 1977 Oct; 4(5):541-7. PubMed ID: 911604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrophotometric determination of diphenylhydantoin.
    Wallace JE
    J Forensic Sci; 1966 Oct; 11(4):552-9. PubMed ID: 5972681
    [No Abstract]   [Full Text] [Related]  

  • 13. Simultaneous quantitation of salivary carbamazepine, carbamazepine-10,11-epoxide, phenytoin and phenobarbitone by high-performance liquid chromatography.
    Herkes GK; McKinnon GE; Eadie MJ
    J Chromatogr; 1989 Nov; 496(1):147-54. PubMed ID: 2592508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating spectrophotometric titration of phenobarbital-diphenylhydantoin combinations in nonaqueous medium.
    Agarwal SP; Blake MI
    Anal Chem; 1969 Jul; 41(8):1104-6. PubMed ID: 5788027
    [No Abstract]   [Full Text] [Related]  

  • 15. Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients.
    Houghton GW; Richens A; Toseland PA; Davidson S; Falconer
    Eur J Clin Pharmacol; 1975 Oct; 9(1):73-8. PubMed ID: 1233256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differentiation of phenobarbital and methylphenobarbital by Pesez's reaction].
    Bouché R
    Ann Pharm Fr; 1972 Oct; 30(10):701-5. PubMed ID: 4656588
    [No Abstract]   [Full Text] [Related]  

  • 17. High performance liquid chromatographic determinations of khellin, phenobarbitone and dipyrone combination in tablets.
    Abounassif MA; Gad-Kariem EA; Wahbi AM
    Farmaco; 1990 Apr; 45(4):465-72. PubMed ID: 2400519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the physicochemical properties of the binary complexes FeL2(OH)1,5H2O and FeP2(OH). Measurement of the pharmacological properties for the compound FeL2(OH)1,5H2O.
    Domínguez A; Jiménez H
    Pharm Acta Helv; 1987; 62(10-11):317-20. PubMed ID: 3438318
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of phenytoin in tablets by second-order derivative ultraviolet spectroscopy.
    Mura P; Santoni G; Pinzauti S
    Pharm Acta Helv; 1987; 62(8):226-8. PubMed ID: 3659059
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary observations on the pharmacokinetics of methylphenobarbitone.
    Eadie MJ; Bochner F; Hooper WD; Tyrer JH
    Clin Exp Neurol; 1978; 15():131-44. PubMed ID: 756009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.